Last reviewed · How we verify
NCT04035980
Telemedicine for Linkage to Care People Who Injected Drugs With Hepatitis C
NA trial testing Telemedicine based healthcare programme in Hepatitis C Virus Infection in 166 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | University of La Laguna |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 166 |
| Start date | 5 July 2019 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Telemedicine based healthcare programme
Conditions studied
- Hepatitis C Virus Infection — all drugs for Hepatitis C Virus Infection →
Sponsor
University of La Laguna
Who can join
18 and older, any sex, with Hepatitis C Virus Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators have designed a community-based intervention study to all subjects attended in drug addiction centers screened for hepatitis C virus (HCV) to evaluate the efficacy and acceptance of a telemedicine based programme versus conventional healthcare assistance
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04035980
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hepatitis C Virus Infection
Currently open trials in the same condition.
- NCT06870019 — Hepatitis C Tracker Study · NA · recruiting
- NCT06463912 — Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia · recruiting
- NCT06718530 — Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Canc · recruiting
- NCT06155006 — Adult Screening for Hepatitis c and Linkage to Treatment in Hospitals in Colombia · recruiting
- NCT06431945 — Early Detection of HCV in Injection Drug Users · recruiting
Other University of La Laguna trials
Trials by the same sponsor.
- NCT07389915 — A Convolutional Neural Network for Difficult Biliary Cannulation · not yet recruiting
- NCT06591364 — Prevalence and Predictive Factors of Difficult Biliary Cannulation · not yet recruiting
- NCT05871814 — Artificial Intelligence and Bowel Cleansing Quality · NA · completed
- NCT05756738 — Acceptance and Feasibility of Hepatitis c Screening Strategies in Social Insertion Centers · NA · unknown
- NCT06576518 — Exercise Intervention in Patients With Metabolic Syndrome and Renal Disease: a Prospective Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04035980 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of La Laguna
- Last refreshed: 18 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04035980.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing